Why paracetamol (acetaminophen) is a suitable first choice for treating mild to moderate acute pain in adults with liver, kidney or cardiovascular disease, gastrointestinal disorders, asthma, or who are older

References

• Ishitsuka Y, Kondo Y, Kadowaki D. Toxicological property of acetaminophen: the dark side of a safe antipyretic/analgesic drug? Biol Pharm Bull. 2020;43(2):195–206.
   PubMed Web of Science ®Google Scholar
• Jóźwiak-Bębenista M, Nowak JZ. Paracetamol: mechanism of action, applications and safety concern. Acta Pol Pharm. 2014;71(1):11–23.
   PubMed Web of Science ®Google Scholar
• Lau SM, McGuire TM, van Driel ML. Consumer concerns about paracetamol: a retrospective analysis of a medicines call centre. BMJ Open. 2016;6(6):e010860.
   PubMed Web of Science ®Google Scholar
• Graham GG, Scott KF, Day RO. Tolerability of paracetamol. Drug Saf. 2005;28(3):227–240.
   PubMed Web of Science ®Google Scholar
• The Gerontological Society of America. An interdisciplinary look at recent FDA policy changes for acetaminophen and the implications for patient care. In: From publication to practice. The Gerontological Society of America. 2011. [cited 2022 Feb 6]. https://secure.geron.org/cvweb/cgi-bin/msascartdll.dll/ProductInfo?productcd=1946_Acetaminophen.
   Google Scholar
• Klotz U. Paracetamol (acetaminophen) - a popular and widely used nonopioid analgesic. Arzneimittelforschung. 2012;62(8):355–359.
   PubMed Web of Science ®Google Scholar
• Hunt RH, Choquette D, Craig BN, et al. Approach to managing musculoskeletal pain: acetaminophen, cyclooxygenase-2 inhibitors, or traditional NSAIDs? Can Fam Physician. 2007;53(7):1177–1184.
   PubMed Web of Science ®Google Scholar
• Gaul C, Eschalier A. Dose can help to achieve effective pain relief for acute mild to moderate pain with over-the-counter paracetamol. Open Pain J. 2018;11(1):12–20.
   Google Scholar
• Graham GG, Davies MJ, Day RO, et al. The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology. 2013;21(3):201–232.
   PubMed Web of Science ®Google Scholar
• Hersch C, Denis C, Sugar D. Frequency, nature and management of patient-reported severe acute pain episodes in the over-the-counter setting: results of an online survey. Pain Manag. 2019;9(4):379–387.
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline Dungarvan Limited. Package leaflet: Panadol optizorb, 500 mg film-coated tablets Paracetamol. GlaxoSmithKline Dungarvan Ltd. County Waterford, Ireland 2019. [cited 2022 Feb 6]. https://www.ravimiregister.ee/Data/PIL_ENG/PIL_26938_ENG.pdf.
   Google Scholar
• Hayward KL, Powell EE, Irvine KM, et al. Can paracetamol (acetaminophen) be administered to patients with liver impairment? Br J Clin Pharmacol. 2016;81(2):210–222.
   PubMed Web of Science ®Google Scholar
• Battaggia A, Lora Aprile P, Cricelli I, et al. Paracetamol: a probably still safe drug. Ann Rheum Dis. 2016;75(9):e57.
   PubMed Web of Science ®Google Scholar
• McCrae JC, Morrison EE, MacIntyre IM, et al. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol. 2018;84(10):2218–2230.
   PubMed Web of Science ®Google Scholar
• Roberts E, Delgado Nunes V, Buckner S, et al. Paracetamol: not as safe as we thought? A systematic literature review of observational studies. Ann Rheum Dis. 2016;75(3):552–559.
   PubMed Web of Science ®Google Scholar
• British Medical Journal. What dose of paracetamol for older people? Drug Ther Bull. 2018;56(6):69–72.
   PubMedGoogle Scholar
• Saab S, Konyn PG, Viramontes MR, et al. Limited knowledge of acetaminophen in patients with liver disease. J Clin Transl Hepatol. 2016;4(4):281–287.
   PubMedGoogle Scholar
• Wolf MS, King J, Jacobson K, et al. Risk of unintentional overdose with non-prescription acetaminophen products. J Gen Intern Med. 2012;27(12):1587–1593.
   PubMed Web of Science ®Google Scholar
• Schweighardt AE, Juba KM. A systematic review of the evidence behind use of reduced doses of acetaminophen in chronic liver disease. J Pain Palliat Care Pharmacother. 2018;32(4):226–239.
   PubMed Web of Science ®Google Scholar
• Chandok N, Watt KDS. Pain management in the cirrhotic patient: the clinical challenge. Mayo Clin Proc. 2010;85(5):451–458.
   PubMed Web of Science ®Google Scholar
• Imani F, Motavaf M, Safari S, et al. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. Hepat Mon. 2014;14(10):e23539.
   PubMed Web of Science ®Google Scholar
• Bosilkovska M, Walder B, Besson M, et al. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. Drugs. 2012;72(12):1645–1669.
   PubMed Web of Science ®Google Scholar
• Lauterburg BH. Analgesics and glutathione. Am J Ther. 2002;9(3):225–233.
   PubMedGoogle Scholar
• Benson GD, Koff RS, Tolman KG. The therapeutic use of acetaminophen in patients with liver disease. Am J Ther. 2005;12(2):133–141.
   PubMedGoogle Scholar
• Caparrotta TM, Antoine DJ, Dear JW. Are some people at increased risk of paracetamol-induced liver injury? A critical review of the literature. Eur J Clin Pharmacol. 2018;74(2):147–160.
   PubMed Web of Science ®Google Scholar
• Massart J, Begriche K, Fromenty B. Cytochrome P450 2E1 should not be neglected for acetaminophen-induced liver injury in metabolic diseases with altered insulin levels or glucose homeostasis. Clin Res Hepatol Gastroenterol. 2021;45(1):101470.
   PubMed Web of Science ®Google Scholar
• Lee SS, Buters JT, Pineau T, et al. Role of CYP2E1 in the hepatotoxicity of acetaminophen. J Biol Chem. 1996;271(20):12063–12067.
   PubMed Web of Science ®Google Scholar
• Kamali F, Thomas SH, Ferner RE. Paracetamol elimination in patients with non-insulin dependent diabetes mellitus. Br J Clin Pharmacol. 1993;35(1):58–61.
   PubMed Web of Science ®Google Scholar
• Stachowiak A, Szałek E, Karbownik A, et al. The influence of diabetes mellitus on glucuronidation and sulphation of paracetamol in patients with febrile neutropenia. Eur J Drug Metab Pharmacokinet. 2019;44(2):289–294.
   PubMed Web of Science ®Google Scholar
• Prescott LF. Therapeutic misadventure with paracetamol: fact or fiction? Am J Ther. 2000;7(2):99–114.
   PubMedGoogle Scholar
• Prescott LF. Paracetamol, alcohol and the liver. Br J Clin Pharmacol. 2000;49(4):291–301.
   PubMed Web of Science ®Google Scholar
• Benson GD. Acetaminophen in chronic liver disease. Clin Pharmacol Ther. 1983;33(1):95–101.
   PubMed Web of Science ®Google Scholar
• Andreasen PB, Hutters L. Paracetamol (acetaminophen) clearance in patients with cirrhosis of the liver. Acta Med Scand Suppl. 1979;624:99–105.
   PubMedGoogle Scholar
• Heard K, Green JL, Bailey JE, et al. A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol. Aliment Pharmacol Ther. 2007;26(2):283–290.
   PubMed Web of Science ®Google Scholar
• Kuffner EK, Green JL, Bogdan GM, et al. The effect of acetaminophen (four grams a day for three consecutive days) on hepatic tests in alcoholic patients–a multicenter randomized study. BMC Med. 2007;5:13.
   PubMed Web of Science ®Google Scholar
• Forrest JA, Adriaenssens P, Finlayson ND, et al. Paracetamol metabolism in chronic liver disease. Eur J Clin Pharmacol. 1979;15(6):427–431.
   PubMed Web of Science ®Google Scholar
• Khalid SK, Lane J, Navarro V, et al. Use of over-the-counter analgesics is not associated with acute decompensation in patients with cirrhosis. Clin Gastroenterol Hepatol. 2009;7(9):994–999.
   PubMed Web of Science ®Google Scholar
• Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. J Gastroenterol Hepatol. 2014;29(7):1356–1360.
   PubMed Web of Science ®Google Scholar
• Hillis WS. Areas of emerging interest in analgesia: cardiovascular complications. Am J Ther. 2002;9(3):259–269.
   PubMedGoogle Scholar
• Kovačević M, Vezmar Kovačević S, Miljković B, et al. The prevalence and preventability of potentially relevant drug-drug interactions in patients admitted for cardiovascular diseases: a cross-sectional study. Int J Clin Pract. 2017;71(10):e13005.
   Web of Science ®Google Scholar
• Antman EM, Bennett JS, Daugherty A, et al. Use of nonsteroidal antiinflammatory drugs: an update for clinicians: a scientific statement from the American Heart Association. Circulation. 2007;115(12):1634–1642.
   PubMed Web of Science ®Google Scholar
• Fanelli A, Ghisi D, Aprile PL, et al. Cardiovascular and cerebrovascular risk with nonsteroidal anti-inflammatory drugs and cyclooxygenase 2 inhibitors: latest evidence and clinical implications. Ther Adv Drug Saf. 2017;8(6):173–182.
   PubMed Web of Science ®Google Scholar
• White WB, Kloner RA, Angiolillo DJ, et al. Cardiorenal safety of OTC analgesics. J Cardiovasc Pharmacol Ther. 2018;23(2):103–118.
   PubMed Web of Science ®Google Scholar
• Schjerning AM, McGettigan P, Gislason G. Cardiovascular effects and safety of (non-aspirin) NSAIDs. Nat Rev Cardiol. 2020;17(9):574–584.
   PubMed Web of Science ®Google Scholar
• Fulton RL, Walters MR, Morton R, et al. Acetaminophen use and risk of myocardial infarction and stroke in a hypertensive cohort. Hypertension. 2015;65(5):1008–1014.
   PubMed Web of Science ®Google Scholar
• Shorog EM, Alburikan KA. The utilization of nonprescription medications in Saudi patients with cardiovascular diseases. Saudi Pharm J. 2018;26(1):120–124.
   PubMed Web of Science ®Google Scholar
• Nguyen QV. Letter by Nguyen regarding article, “Acetaminophen increases blood pressure in patients with coronary artery disease”. Circulation. 2011;123(25):e645.
   PubMed Web of Science ®Google Scholar
• Chan AT, Manson JE, Albert CM, et al. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events. Circulation. 2006;113(12):1578–1587.
   PubMed Web of Science ®Google Scholar
• Turtle EJ, Dear JW, Webb DJ. A systematic review of the effect of paracetamol on blood pressure in hypertensive and non-hypertensive subjects. Br J Clin Pharmacol. 2013;75(6):1396–1405.
   PubMed Web of Science ®Google Scholar
• Montgomery B. Does paracetamol cause hypertension? BMJ. 2008;336(7654):1190–1191.
   PubMed Web of Science ®Google Scholar
• Curhan GC, Willett WC, Rosner B, et al. Frequency of analgesic use and risk of hypertension in younger women. Arch Intern Med. 2002;162(19):2204–2208.
   PubMed Web of Science ®Google Scholar
• Forman JP, Rimm EB, Curhan GC. Frequency of analgesic use and risk of hypertension among men. Arch Intern Med. 2007;167(4):394–399.
   PubMed Web of Science ®Google Scholar
• Dedier J, Stampfer MJ, Hankinson SE, et al. Nonnarcotic analgesic use and the risk of hypertension in US women. Hypertension. 2002;40(5):604–608.
   PubMed Web of Science ®Google Scholar
• Dawson J, Fulton R, McInnes GT, et al. Acetaminophen use and change in blood pressure in a hypertensive population. J Hypertens. 2013;31(7):1485–1490.
   PubMed Web of Science ®Google Scholar
• Kurth T, Hennekens CH, Stürmer T, et al. Analgesic use and risk of subsequent hypertension in apparently healthy men. Arch Intern Med. 2005;165(16):1903–1909.
   PubMedGoogle Scholar
• Aljadhey H, Tu W, Hansen RA, et al. Comparative effects of non-steroidal anti-inflammatory drugs (NSAIDs) on blood pressure in patients with hypertension. BMC Cardiovasc Disord. 2012;12:93.
   PubMed Web of Science ®Google Scholar
• Pavličević I, Kuzmanić M, Rumboldt M, et al. Interaction between antihypertensives and NSAIDs in primary care: a controlled trial. Can J Clin Pharmacol. 2008;15(3):e372–382.
   Google Scholar
• Ubeda A, Llopico J, Sanchez MT. Blood pressure reduction in hypertensive patients after withdrawal of effervescent medication. Pharmacoepidem Drug Safe. 2009;18(5):417–419.
   PubMed Web of Science ®Google Scholar
• Benitez-Camps M, Morros Padrós R, Pera-Pujadas H, et al. Effect of effervescent paracetamol on blood pressure: a crossover randomized clinical trial. J Hypertens. 2018;36(8):1656–1662.
   PubMed Web of Science ®Google Scholar
• Jarrett DR. Paracetamol and hypertension: time to label sodium in drug treatments? BMJ. 2008;336(7657):1324.
   PubMed Web of Science ®Google Scholar
• Chalmers JP, West MJ, Wing LM, et al. Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients. Clin Exp Hypertens A. 1984;6(6):1077–1093.
   PubMed Web of Science ®Google Scholar
• Furey SA, Vargas R, McMahon FG. Renovascular effects of nonprescription ibuprofen in elderly hypertensive patients with mild renal impairment. Pharmacotherapy. 1993;13(2):143–148.
   PubMed Web of Science ®Google Scholar
• Radack KL, Deck CC, Bloomfield SS. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen. Ann Intern Med. 1987;107(5):628–635.
   PubMed Web of Science ®Google Scholar
• Sudano I, Flammer AJ, Périat D, et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation. 2010;122(18):1789–1796.
   PubMed Web of Science ®Google Scholar
• MacIntyre IM, Turtle EJ, Farrah TE, et al. Regular acetaminophen use and blood pressure in people with hypertension: the PATH-BP trial. Circulation. 2022;145(6):416–423.
   PubMed Web of Science ®Google Scholar
• The University of Edinburgh. Regular paracetamol use linked to raised blood pressure [press release]. The University of Edinburgh. Latest news. 2022 Feb 8. [cited 2022 Feb 10]. https://www.ed.ac.uk/news/2022/regular-paracetamol-use-linked-to-high-blood-press.
   Google Scholar
• Merlo J, Broms K, Lindblad U, et al. Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish population. Eur J Clin Pharmacol. 2001;57(1):71–75.
   PubMed Web of Science ®Google Scholar
• Schwarz ES, Mullins ME. Paracetamol: is all the concern valid? Ann Rheum Dis. 2015;74(8):e48.
   PubMed Web of Science ®Google Scholar
• Girard P, Sourdet S, Cantet C, et al. Acetaminophen safety: risk of mortality and cardiovascular events in nursing home residents, a prospective study. J Am Geriatr Soc. 2019;67(6):1240–1247.
   PubMed Web of Science ®Google Scholar
• Bannwarth B. Gastrointestinal safety of paracetamol: is there any cause for concern? Expert Opin Drug Saf. 2004;3(4):269–272.
   PubMedGoogle Scholar
• Weil J, Colin-Jones D, Langman M, et al. Prophylactic aspirin and risk of peptic ulcer bleeding. BMJ. 1995;310(4):827–830.
   PubMed Web of Science ®Google Scholar
• Lewis SC, Langman MJ, Laporte JR, et al. Dose-response relationships between individual nonaspirin nonsteroidal anti-inflammatory drugs (NANSAIDs) and serious upper gastrointestinal bleeding: a meta-analysis based on individual patient data. Br J Clin Pharmacol. 2002;54(3):320–326.
   PubMed Web of Science ®Google Scholar
• Savage RL, Moller PW, Ballantyne CL, et al. Variation in the risk of peptic ulcer complications with nonsteroidal antiinflammatory drug therapy. Arthritis Rheum. 1993;36(1):84–90.
   PubMed Web of Science ®Google Scholar
• Garcia Rodríguez LA, Hernández-Díaz S. The risk of upper gastrointestinal complications associated with nonsteroidal anti-inflammatory drugs, glucocorticoids, acetaminophen, and combinations of these agents. Arthritis Res. 2001;3(2):98–101.
   PubMedGoogle Scholar
• Rahme E, Pettitt D, LeLorier J. Determinants and sequelae associated with utilization of acetaminophen versus traditional nonsteroidal antiinflammatory drugs in an elderly population. Arthritis Rheum. 2002;46(11):3046–3054.
   PubMed Web of Science ®Google Scholar
• Krishnasamy S, Abell TL. Diabetic gastroparesis: principles and current trends in management. Diabetes Ther. 2018;9(Suppl 1):1–42.
   PubMed Web of Science ®Google Scholar
• Severijnen R, Bayat N, Bakker H, et al. Enteral drug absorption in patients with short small bowel: a review. Clin Pharmacokinet. 2004;43(14):951–962.
   PubMed Web of Science ®Google Scholar
• Kelly K, O’Mahony B, Lindsay B, et al. Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy. Pharm Res. 2003;20(10):1668–1673.
   PubMed Web of Science ®Google Scholar
• GlaxoSmithKline. A two part pivotal pharmacokinetic study to evaluate the exposure and variability in absorption of paracetamol from a fast-dissolving tablet. In: GSK study register. GSK. 2005 [cited 2022 Feb 6]. https://www.gsk-studyregister.com/en/trial-details/?id=A1900265#documents-section.
   Google Scholar
• GlaxoSmithKline. A proof-of-principle study to evaluate the absorption of paracetamol in a gastric dysmotiliy model. In: GSK study register. GSK. 2006 [cited 2022 Feb 6]. https://www.gsk-studyregister.com/en/trial-details/?id=A1900385#documents-section.
   Google Scholar
• Wójcicki J, Gawrońska-Szklarz B. Pharmacokinetics of paracetamol in patients with gastric and duodenal ulcers. Pol J Pharmacol Pharm. 1984;36(1):59–63.
   PubMedGoogle Scholar
• Haderslev KV, Sonne J, Poulsen HE, et al. Paracetamol metabolism in patients with ulcerative colitis. Br J Clin Pharmacol. 1998;46(5):513–516.
   PubMed Web of Science ®Google Scholar
• Davison SN. Clinical pharmacology considerations in pain management in patients with advanced kidney failure. Clin J Am Soc Nephrol. 2019;14(6):917–931.
   PubMed Web of Science ®Google Scholar
• Pham PC, Khaing K, Sievers TM, et al. 2017 Update on pain management in patients with chronic kidney disease. Clin Kidney J. 2017;10(5):688–697.
   PubMed Web of Science ®Google Scholar
• Davison SN, Rathwell S, George C, et al. Analgesic use in patients with advanced chronic kidney disease: a systematic review and meta-analysis. Can J Kidney Health Dis. 2020;7:2054358120910329.
   Google Scholar
• Smyth B, Jones C, Saunders J. Prescribing for patients on dialysis. Aust Prescr. 2016;39(1):21–24.
   PubMedGoogle Scholar
• Park WY. Controversies in acetaminophen nephrotoxicity. Kidney Res Clin Pract. 2020;39(1):4–6.
   PubMed Web of Science ®Google Scholar
• Evans M, Fored CM, Bellocco R, et al. Acetaminophen, aspirin and progression of advanced chronic kidney disease. Nephrol Dial Transplant. 2009;24(6):1908–1918.
   PubMed Web of Science ®Google Scholar
• Mihatsch MJ, Khanlari B, Brunner FP. Obituary to analgesic nephropathy–an autopsy study. Nephrol Dial Transplant. 2006;21(11):3139–3145.
   PubMed Web of Science ®Google Scholar
• Henrich WL, Agodoa LE, Barrett B, et al. Analgesics and the kidney: summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation. Am J Kidney Dis. 1996;27(1):162–165.
   PubMed Web of Science ®Google Scholar
• Blantz RC. Acetaminophen: acute and chronic effects on renal function. Am J Kidney Dis. 1996;28(1 Suppl 1):S3–S6.
   PubMed Web of Science ®Google Scholar
• Hiragi S, Yamada H, Tsukamoto T, et al. Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study. Clin Epidemiol. 2018;10:265–276.
   PubMed Web of Science ®Google Scholar
• Barrett BJ. Acetaminophen and adverse chronic renal outcomes: an appraisal of the epidemiologic evidence. Am J Kidney Dis. 1996;28(1 Suppl 1):S14–S19.
   PubMed Web of Science ®Google Scholar
• Harris RC, Breyer MD. Update on cyclooxygenase-2 inhibitors. Clin J Am Soc Nephrol. 2006;1(2):236–245.
   PubMed Web of Science ®Google Scholar
• Graham GG, Graham RI, Day RO. Comparative analgesia, cardiovascular and renal effects of celecoxib, rofecoxib and acetaminophen (paracetamol). Curr Pharm Des. 2002;8(12):1063–1075.
   PubMed Web of Science ®Google Scholar
• Suprapti B, Nilamsari WP, Rachmania , et al. Medical problems in patients with chronic kidney disease undergoing hemodialysis and their therapy. J Basic Clin Physiol Pharmacol. 2019;30(6):jbcpp-2019-0250.
   PubMedGoogle Scholar
• Barr RG, Wentowski CC, Curhan GC, et al. Prospective study of acetaminophen use and newly diagnosed asthma among women. Am J Respir Crit Care Med. 2004;169(7):836–841.
   PubMed Web of Science ®Google Scholar
• Thomsen SF, Kyvik KO, Skadhauge L, et al. Intake of paracetamol and risk of asthma in adults. J Asthma. 2008;45(8):675–676.
   PubMed Web of Science ®Google Scholar
• Kelkar M, Cleves MA, Foster HR, et al. Prescription-acquired acetaminophen use and the risk of asthma in adults: a case-control study. Ann Pharmacother. 2012;46(12):1598–1608.
   PubMed Web of Science ®Google Scholar
• Davey G, Berhane Y, Duncan P, et al. Use of acetaminophen and the risk of self-reported allergic symptoms and skin sensitization in Butajira, Ethiopia. J Allergy Clin Immunol. 2005;116(4):863–868.
   PubMed Web of Science ®Google Scholar
• Shaheen SO, Sterne JA, Songhurst CE, et al. Frequent paracetamol use and asthma in adults. Thorax. 2000;55(4):266–270.
   PubMed Web of Science ®Google Scholar
• Shaheen S, Potts J, Gnatiuc L, et al; GA2LEN. The relation between paracetamol use and asthma: a GA2LEN european case-control study. Eur Respir J. 2008;32(5):1231–1236.
   PubMed Web of Science ®Google Scholar
• McKeever TM, Lewis SA, Smit HA, et al. The association of acetaminophen, aspirin, and ibuprofen with respiratory disease and lung function. Am J Respir Crit Care Med. 2005;171(9):966–971.
   PubMed Web of Science ®Google Scholar
• Etminan M, Sadatsafavi M, Jafari S, et al. Acetaminophen use and the risk of asthma in children and adults: a systematic review and metaanalysis. Chest. 2009;136(5):1316–1323.
   PubMed Web of Science ®Google Scholar
• Ioannides SJ, Williams M, Jefferies S, et al. Randomised placebo-controlled study of the effect of paracetamol on asthma severity in adults. BMJ Open. 2014;4(2):e004324.
   PubMed Web of Science ®Google Scholar
• Weatherall M, Ioannides S, Braithwaite I, et al. The association between paracetamol use and asthma: causation or coincidence? Clin Exp Allergy. 2015;45(1):108–113.
   PubMed Web of Science ®Google Scholar
• Levy S, Volans G. The use of analgesics in patients with asthma. Drug Saf. 2001;24(11):829–841.
   PubMed Web of Science ®Google Scholar
• Lourido-Cebreiro T, Salgado FJ, Valdes L, et al. The association between paracetamol and asthma is still under debate. J Asthma. 2017;54(1):32–38.
   PubMed Web of Science ®Google Scholar
• Karakaya G, Kalyoncu AF. Paracetamol and asthma. Expert Opin Pharmacother. 2003;4(1):13–21.
   PubMed Web of Science ®Google Scholar
• Ichinose M, Sugiura H, Nagase H, et al. Japanese guidelines for adult asthma 2017. Allergol Int. 2017;66(2):163–189.
   PubMed Web of Science ®Google Scholar
• Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced asthma and its implications for clinical practice. BMJ. 2004;328(7437):434.
   PubMed Web of Science ®Google Scholar
• Settipane RA, Schrank PJ, Simon RA, et al. Prevalence of cross-sensitivity with acetaminophen in aspirin-sensitive asthmatic subjects. J Allergy Clin Immunol. 1995;96(4):480–485.
   PubMed Web of Science ®Google Scholar
• American Academy of Allergy Asthma & Immunology. Aspirin-Exacerbated Respiratory Disease (AERD). In: AAAAI library articles: asthma. AAAAI. 2020 [cited 2022 Feb 6]. https://www.aaaai.org/Tools-for-the-Public/Conditions-Library/Asthma/Aspirin-Exacerbated-Respiratory-Disease-(AERD).
   Google Scholar
• Herr KA, Garand L. Assessment and measurement of pain in older adults. Clin Geriatr Med. 2001;17(3):457–478.
   PubMed Web of Science ®Google Scholar
• Abdulla A, Adams N, Bone M, et al. Guidance on the management of pain in older people. Age Ageing. 2013;42(Suppl 1):i1–i57.
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Murnion BP, Hilmer SN. Age and opioid analgesia in an acute hospital population. Age Ageing. 2008;37(6):699–702.
   PubMed Web of Science ®Google Scholar
• Mitchell SJ, Hilmer SN, Murnion BP, et al. Hepatotoxicity of therapeutic short-course paracetamol in hospital inpatients: impact of ageing and frailty. J Clin Pharm Ther. 2011;36(3):327–335.
   PubMed Web of Science ®Google Scholar
• McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. Br J Clin Pharmacol. 2011;71(3):351–364.
   PubMed Web of Science ®Google Scholar
• Aubrun F, Marmion F. The elderly patient and postoperative pain treatment. Best Pract Res Clin Anaesthesiol. 2007;21(1):109–127.
   PubMedGoogle Scholar
• Mian P, Allegaert K, Spriet I, et al. Paracetamol in older people: towards evidence-based dosing? Drugs Aging. 2018;35(7):603–624.
   PubMed Web of Science ®Google Scholar
• Falzone E, Hoffmann C, Keita H. Postoperative analgesia in elderly patients. Drugs Aging. 2013;30(2):81–90.
   PubMed Web of Science ®Google Scholar
• Kaas Oldenburg LI, Dalhoff KP, Sandoval LØ, et al. The risk of drug-drug interactions with paracetamol in a population of hospitalized geriatric patients. J Pharm (Cairo). 2020;2020:1354209.
   PubMed Web of Science ®Google Scholar
• Sharma CV, Mehta V. Paracetamol: mechanisms and updates. Contin Educ Anaesth Crit Care Pain. 2014;14(4):153–158.
   Google Scholar
• Toes MJ, Jones AL, Prescott L. Drug interactions with paracetamol. Am J Ther. 2005;12(1):56–66.
   PubMedGoogle Scholar
• Hias J, Van der Linden L, Walgraeve K, et al. Pharmacokinetics of 2 oral paracetamol formulations in hospitalized octogenarians. Br J Clin Pharmacol. 2022;88(3):1020–1030.
   PubMed Web of Science ®Google Scholar
• Horowitz M, Maddern GJ, Chatterton BE, et al. Changes in gastric emptying rates with age. Clin Sci (Lond). 1984;67(2):213–218.
   PubMed Web of Science ®Google Scholar
• Soenen S, Rayner CK, Horowitz M, et al. Gastric emptying in the elderly. Clin Geriatr Med. 2015;31(3):339–353.
   PubMed Web of Science ®Google Scholar
• Gainsborough N, Maskrey VL, Nelson ML, et al. The association of age with gastric emptying. Age Ageing. 1993;22(1):37–40.
   PubMed Web of Science ®Google Scholar
• Triggs EJ, Nation RL, Long A, et al. Pharmacokinetics in the elderly. Eur J Clin Pharmacol. 1975;8(1):55–62.
   PubMed Web of Science ®Google Scholar
• Liukas A, Kuusniemi K, Aantaa R, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. Clin Pharmacokinet. 2011;50(2):121–129.
   PubMed Web of Science ®Google Scholar
• Divoll M, Abernethy DR, Ameer B, et al. Acetaminophen kinetics in the elderly. Clin Pharmacol Ther. 1982;31(2):151–156.
   PubMed Web of Science ®Google Scholar
• Bannwarth B, Pehourcq F, Lagrange F, et al. Single and multiple dose pharmacokinetics of acetaminophen (paracetamol) in polymedicated very old patients with rheumatic pain. J Rheumatol. 2001;28(1):182–184.
   PubMed Web of Science ®Google Scholar
• Miners JO, Penhall R, Robson RA, et al. Comparison of paracetamol metabolism in young adult and elderly males. Eur J Clin Pharmacol. 1988;35(2):157–160.
   PubMed Web of Science ®Google Scholar
• Mian P, van Esdonk MJ, Olkkola KT, et al. Population pharmacokinetic modelling of intravenous paracetamol in fit older people displays extensive unexplained variability. Br J Clin Pharmacol. 2019;85(1):126–135.
   PubMed Web of Science ®Google Scholar
• Agier MS, Chollet N, Bediou E, et al. Transient major hypothermia associated with acetaminophen: a pediatric case report and literature review. Arch Pediatr. 2019;26(6):358–360.
   PubMed Web of Science ®Google Scholar
• Foster J, Mauger A, Thomasson K, et al. Effect of acetaminophen ingestion on thermoregulation of normothermic, non-febrile humans. Front Pharmacol. 2016;7:54. Erratum in: Front Pharmacol. 2016;7:93.
   PubMed Web of Science ®Google Scholar
• Foster J, Mauger AR, Govus A, et al. Acetaminophen (paracetamol) induces hypothermia during acute cold stress. Clin Drug Investig. 2017;37(11):1055–1065.
   PubMed Web of Science ®Google Scholar